In 63 clinical sites and 8 countries around the world, physicians who specialize in the treatment of Cystic Fibrosis (CF) are actively recruiting patients for a clinical study of a new investigational CF medication called Inhaled Ciprofloxacin (a dry powder antibiotic inhaled via a handheld portable device).

The doctors conducting the study would make the final determination for your (or your child’s) eligibility. You (or your child) may qualify for the study if you meet the following initial criteria:

§ Have a documented diagnosis of Cystic Fibrosis (this study is open to all CF patients regardless of specific

§ genotype/genetic mutation)

§ Are at least 12 years of age

§ Culture positive for P. aeruginosa in the past 12 months

To obtain information about participating clinics please call the number below.

1-888-842-2937 (select menu option 3 or 4)

You can also click on the links below to view the complete listing of eligibility criteria for this trial as well as a listing of all 63 participating clinics worldwide.

Click here to view the complete study profile at ClinicalTrials.gov

Click here to view the detailed study profile for U.S. sites at the web site of the Cystic Fibrosis Foundation

Contact your doctor if you are interested in participating in this clinical trial.

Additional information:

§ Qualified participants will not be charged for the visits, tests, and treatments provided as part of this study

§ You may receive a stipend for travel and expenses

§ Your involvement should last approximately 90 days

Study sponsored by

Bayer HealthCare Pharmaceuticals Inc